Low Endotoxin Purified Anti-Mouse CD90.1 Antibody [19E12] (AGEL2189)
- SKU:
- AGEL2189
- Product Type:
- Antibody
- Antibody Type:
- Monoclonal Antibody
- Applications:
- FCM
- Reactivity:
- Mouse
- Host Species:
- Rat
- Isotype:
- Rat IgG2a, κ
- Clone:
- 19E12
- Conjugation:
- None (Low endotoxin)
Frequently bought together:
Description
Product Title: | Low Endotoxin Purified Anti-Mouse CD90.1 Antibody [19E12] |
SKU: | AGEL2189 |
Size: | 50µg, 500µg, 1mg |
Clone No: | 19E12 |
Synonyms: | Thy-1.1 membrane glycoprotein;Thy1.1;Thy-1.1 antigen;CD90.1;Thy-1.1; |
Host Species: | Rat |
Reactivity: | Mouse |
Application: | FCM |
Isotype: | Rat IgG2a, κ |
Isotype Control: | AF/LE Purified Rat IgG2a, κ Isotype Control[2A3] |
Form: | Liquid |
Conjugation: | None (AF/LE) |
Recommended Use: | Each lot of this antibody is quality control tested by flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 2.0 µg per 106 cells in 100 µL volume or 100 µL of whole blood. It is recommended that the reagent be titrated for optimal performance for each application. |
Gene ID: | 21838 |
Storage Buffer: | 0.2 μm filtered in PBS, pH 7.2. Azide Free (AF)/Low Endotoxin (LE): Contains no stabilizers or stabilizers. Endotoxin level is < 2 EU/mg as Determined by LAL gel clotting assay. |
Stability & Storage: | Keep as concentrated solution. Store at 2~8°C and protected from prolonged exposure to light. Do not freeze. Centrifuge before opening to ensure complete recovery of vial contents. This product is guaranteed up to one year from purchase. |
Background: | CD90.1 is a 25-35 kD immunoglobulin superfamily member, also known as Thy-1. It is expressed on hematopoietic stem cells and neurons, all thymocytes, and peripheral T cells. CD90.1 is a glycosylphosphatidylinositol (GPI)-anchored membrane glycoprotein involved in signal transduction. CD90.1 is involved in costimulation of lymphocyte proliferation and activation, and hematopoietic stem cell differentiation. CD90.1 has been shown to interact with CD45. |